Abstract

to study myocardial contractile function in patients with liver cirrhosis and ascites in the presence of bacterial overgrowthsyndrome (BOS) and pathological bacterial translocation. We included in this study 59 patientswith Child-Pugh class B and C liver cirrhosis (LC) of various etiology and ascites. Control group comprised 12 patients withischemic heart disease complicated by chronic heart failure (CHF). Examination included history taking and laboratory andinstrumental investigation. LC was diagnosed basing on clinical symptoms and instrumental studies. Child-Pugh and MELDscores were used for assessment of LC severity and prognosis. International ascites club grading system was used for evaluationof severity of ascites. Hydrogen breath test was applied for diagnosing BOS. Syndrome of pathological bacterial translocationwas established based on blood levels of lipopolysaccharide-binding protein and detection of bacterial DNA in ascitic fluid.Structural-functional parameters of the myocardium and hemodynamics were assessed by echocardiography. Brain natriureticpeptide (BNP) concentration was measured in blood serum and ascitic fluid. In 13 of 59 patients with LC the hydrogenbreath test was negative, in 33 positive and in 13 patients the positive hydrogen test was combined with the presence of BOSand pathological bacterial translocation. Blood serum and ascitic fluid BNP concentrations in LC patients were low and withinnormal limits (62.5±4.1 and 53.3±4.9 rg / ml, respectively), what contrasted with high BNP concentrations in patients withCHF (1820±95.5 and 497.1±39.6 rg / ml, respectively). Total protein level in ascitic fluid also was significantly lower in patientswith LC than in patients with CHF (1.77±0.1 and 4.43±0.35 mg / dL, respectively). The serum-ascitic albumin gradient(SAAG) in both groups of patients exceeded 1.1 (1.58±0.13 in patients with CHF and 1.88±0.19 in patients with LC).Conclusions. In patients with liver cirrhosis the presence of BOS and bacterial translocation did not produce a distinct negativeimpact on contractile function.

Highlights

  • У пациентов с циррозом печени (ЦП) могут обнаруживаться различные нарушения сердечно-сосудистой системы, включая повышение сердечного выброса, снижение систолической сократительной функции и функции диастолического расслабления, ограничение ответа на β1‐адренергическую стимуляцию, что рядом авторов рассматривается в целом как проявления так называемой цирротической кардиомиопатии [5]

  • We included in this study 59 patients with Child-Pugh class B and C liver cirrhosis

  • 12 patients with ischemic heart disease complicated by chronic heart failure

Read more

Summary

Introduction

У пациентов с ЦП могут обнаруживаться различные нарушения сердечно-сосудистой системы, включая повышение сердечного выброса, снижение систолической сократительной функции и функции диастолического расслабления, ограничение ответа на β1‐адренергическую стимуляцию, что рядом авторов рассматривается в целом как проявления так называемой цирротической кардиомиопатии [5]. Следовательно, у пациентов с ЦП в зависимости от тяжести состояния при наличии «цирротической кардиомиопатии» возможно повышение уровня BNP [6, 7]

Objectives
Findings
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call